What is the treatment and management for conjunctivitis in individuals of all ages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment and Management of Conjunctivitis

Most conjunctivitis is self-limited and requires only supportive care, but specific etiologies—particularly gonococcal, chlamydial, and immune-mediated forms—demand immediate targeted therapy to prevent vision-threatening complications. 1

Initial Diagnostic Approach

The first priority is distinguishing conjunctivitis from vision-threatening conditions and identifying cases requiring urgent intervention. 1

Key red flags requiring immediate ophthalmology referral: 2, 3

  • Visual loss or moderate-to-severe pain
  • Corneal involvement on fluorescein staining
  • Copious purulent discharge (suggests gonococcal infection)
  • History of recent ocular surgery
  • Immunocompromised state
  • Lack of response after 3-4 days of appropriate therapy

Perform slit-lamp biomicroscopy with fluorescein staining to evaluate for corneal involvement, which fundamentally changes management. 4, 2

Hyperacute Purulent Conjunctivitis (Gonococcal)

This is a medical emergency requiring immediate systemic antibiotics without waiting for culture results. 5

Clinical Recognition

  • Copious purulent discharge with marked eyelid edema 5
  • Rapid onset (within 24 hours) 5
  • Preauricular lymphadenopathy 5
  • Critical finding: Superior corneal infiltrates or ulcers that can progress to perforation within 24 hours 5

Immediate Management

Systemic therapy (do not rely on topical antibiotics alone): 5

  • Ceftriaxone 1g IM/IV immediately 5
  • Add azithromycin 1g PO single dose (or doxycycline 100mg twice daily for 7 days) for presumed chlamydial coinfection 5
  • Consider saline lavage to reduce bacterial load 5

Obtain conjunctival cultures and Gram stain but initiate treatment immediately. 2

Special Populations

  • Neonates (1-7 days after birth): Represents ophthalmia neonatorum; requires same systemic therapy 1, 5
  • Children: Consider and document sexual abuse 1, 5, 2
  • Sexually active adults: Screen for concurrent genital infection and treat partners 5

Follow-up within 24-48 hours to assess treatment response and monitor for corneal complications. 5

Chlamydial Conjunctivitis

Inclusion Conjunctivitis (Serotypes D-K)

Clinical features: 1

  • Follicular conjunctivitis with follicles on bulbar conjunctiva and semilunar fold (distinctive finding) 1
  • Chronic course with corneal pannus and subepithelial infiltrates 1
  • Sexually transmitted; highly communicable 1

Treatment requires systemic antibiotics: 1, 5

  • Azithromycin 1g PO single dose, OR
  • Doxycycline 100mg twice daily for 7 days
  • Treat sexual partners 1

Trachoma (Serotypes A, B, C)

  • Endemic in areas without adequate water/sanitation 1
  • Requires systemic azithromycin for mass drug administration programs 1
  • Leading infectious cause of global blindness if untreated 1

Bacterial Conjunctivitis (Non-Gonococcal)

Most cases are self-limited, resolving in 1-2 weeks without treatment. 3, 6

Clinical Features Suggesting Bacterial Etiology

  • Mucopurulent discharge with eyelids matted shut on waking 3, 6
  • Lack of itching 6
  • No history of recurrent conjunctivitis 6
  • More common in children 3

Treatment Strategy

Delayed antibiotic prescribing is appropriate for uncomplicated cases and provides similar symptom control to immediate prescribing. 3, 6

Indications for topical antibiotics: 1, 3

  • Desire for earlier return to school/work 6
  • Contact lens wearers (requires treatment) 6
  • Immunocompromised patients 3

No evidence supports superiority of any specific topical antibiotic. 1

FDA-approved topical options: 7, 8

  • Bacitracin ophthalmic ointment: Apply to conjunctival sac 1-3 times daily 7
  • Erythromycin ophthalmic ointment: Apply to conjunctival sac 8

Critical pitfall: Indiscriminate antibiotic use should be avoided as viral conjunctivitis will not respond and mild bacterial cases are self-limited. 1

Viral Conjunctivitis

Viral conjunctivitis is the most common overall cause of infectious conjunctivitis and typically requires only supportive care. 6, 9

Clinical Features

  • Watery discharge (not purulent) 3
  • More common in adults 3
  • Adenovirus accounts for approximately 80% of viral cases 9
  • Preauricular lymphadenopathy may be present 9

Supportive Management

  • Artificial tears 3
  • Cold compresses 3
  • Topical antihistamine eye drops for symptom relief 3

Infection Control (Critical for Epidemic Adenoviral Conjunctivitis)

The ophthalmologist plays a critical role in breaking the chain of transmission: 1

  • Counsel patients on frequent handwashing 1
  • Use separate towels 1
  • Avoid close contact during contagious period 1
  • Disinfect tonometers with dilute bleach (1:10 sodium hypochlorite) 1
  • Do not use 70% isopropyl alcohol, 3% hydrogen peroxide, or ethyl alcohol for tonometer disinfection 1
  • Disinfect surfaces with EPA-registered hospital disinfectant 1

Herpes simplex viral conjunctivitis requires specific diagnosis before using corticosteroid eye solutions, as steroids are contraindicated in HSV. 9

Allergic Conjunctivitis

Affects up to 40% of the population; itching is the most consistent sign. 6

Treatment

Topical antihistamines with mast cell-stabilizing activity are first-line therapy. 3, 6

Clinical Features

  • Itching (hallmark symptom) 6
  • Watery discharge 3
  • Bilateral presentation 6

Contact Lens-Related Conjunctivitis

Requires discontinuation of contact lens wear. 1

Clinical Features

  • Ranges from mild to diffuse conjunctival injection 1
  • Papillary hypertrophy of superior tarsal conjunctiva (Giant Papillary Conjunctivitis) 1
  • May take months to resolve even with treatment and lens withdrawal 1

Risk Factors

  • Soft contact lenses, infrequent replacement, prolonged wearing time, poor hygiene 1

Potential Complications

  • Corneal neovascularization, superior limbal stem cell deficiency 1

Immune-Mediated Conjunctivitis Requiring Early Detection

These conditions require systemic treatment and early detection is critical: 1

Ocular Mucous Membrane Pemphigoid (OMMP)

  • Bilateral bulbar conjunctival injection with papillary reaction 1
  • Progressive conjunctival scarring 1
  • Requires systemic immunosuppression 1

Graft-Versus-Host Disease (GVHD)

  • Important to detect early for systemic management 1

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

  • Bilateral conjunctival involvement with potential for severe mucocutaneous necrosis 4
  • Conjunctival scarring and subepithelial fibrosis 4

Juvenile Dermatomyositis

  • Limbic-sparing conjunctivitis is characteristic 4
  • May present with systemic manifestations including weakness and elevated liver enzymes 4

Medication-Induced Conjunctivitis

Obtain comprehensive medication history including recent antibiotics, anticonvulsants, or topical eye medications. 4

Clinical Features

  • Conjunctival injection, punctal edema, inferior fornix follicles 1
  • Contact dermatitis of eyelids with erythema and scaling 1
  • Most common with multiple eye medications and frequent dosing 1

Topical corticosteroids should be avoided indiscriminately as they can worsen certain conditions. 1

Prevention

Herpes Zoster vaccination should be strongly recommended in patients 50 years or older. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bacterial Conjunctivitis Treatment in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Guideline

Diagnostic Approach to Limbic-Sparing Conjunctivitis and Systemic Involvement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperacute Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Viral Conjunctivitis.

Viruses, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.